Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities

BACKGROUND: Data on mepolizumab in patients with severe eosinophilic asthma (EA) and comorbidities are needed to assess whether randomized controlled trial results are applicable in the real world. OBJECTIVE: To evaluate real-life effectiveness and the presence/absence of predictors of treatment res...

Descripción completa

Detalles Bibliográficos
Autores principales: Crimi, Claudia, Campisi, Raffaele, Cacopardo, Giulia, Intravaia, Rossella, Nolasco, Santi, Porto, Morena, Pelaia, Corrado, Crimi, Nunzio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508691/
https://www.ncbi.nlm.nih.gov/pubmed/32994855
http://dx.doi.org/10.1016/j.waojou.2020.100462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508691/
https://www.ncbi.nlm.nih.gov/pubmed/32994855
http://dx.doi.org/10.1016/j.waojou.2020.100462

Ejemplares similares